T
We are focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. We are committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. Please see our social media community guidelines at http://bit.ly/1UVcx0L
Investor insights
Funding rounds participated in
$46M sweet spot round size
Investor type
Public Company
Basic info
Industry
Medical Device
Sectors
Medical Device
Funding rounds raised
Total raised
$46M
from investors over 1 rounds
T
TELA Bio raised $46M on November 23, 2024